A recent study found PATZ1 among the top ten transcriptional factors strongly associated with the renal cell carcinoma (RCC), indicating that PATZ1 might be used as biomarker of RCC for accurate diagnosis, prognosis and/or treatment efficiency [58]. This evidence concerns the gene PATZ1 and renal cell carcinoma.